GI
ELV icon

Gavea Investimentos’s Elevance Health ELV Stock Holding History

Gavea Investimentos’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-10,000
Closed -$2.69M – 18
2020
Q3 		$2.69M Buy
+10,000
New +$2.69M 6.41% 6

Other funds holding ELV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Gavea Investimentos's ELV Position: Q4 2020 in Review

Gavea Investimentos sold out of Elevance Health (ELV) in Q4 2020, closing a stake of 10,000 shares — an estimated $2.69M sold.

Gavea Investimentos first reported a position in ELV in Q3 2020 and held it in 1 quarter. The position peaked at $2.69M in Q3 2020. 1,173 funds tracked by Wall St. Rank hold ELV as of Q4 2020.

  • Gavea Investimentos reported no remaining Elevance Health position as of Q4 2020 after selling out during the quarter.
  • Gavea Investimentos sold 10,000 Elevance Health shares in Q4 2020, an estimated $2.69M.
  • Gavea Investimentos first reported a position in Elevance Health in Q3 2020 and held it in 1 quarter.
  • Gavea Investimentos's Elevance Health position peaked at $2.69M in Q3 2020.
  • 1,173 funds tracked by Wall St. Rank held Elevance Health as of Q4 2020.

Based on Gavea Investimentos's 13F filing for Q4 2020, filed 16 Feb 2021.